Inactivating mutations and overexpression of BCL 10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32)

Nature Genetics

Volumn 22, Issue 1, 1999, Pages 63-68

  Zhang, Quangeng ^a   Siebert, Reiner ^k   Yan, Minhong ^c   Hinzmann, Bernd ^d   Cui, Xiaoli ^a   Xue, Liquan ^a   Rakestraw, Karen M ^a   Naeve, Clayton W ^a   Beckmann, Georg ^d   Weisenburger, Dennis D ^e   Sanger, Warren G ^e,f   Nowotny, Hadwiga ^g   Vesely, Michael ^h   Callet Bauchu, Evelyne ⁱ   Salles, Gilles ^j   Dixit, Vishva M ^c   Rosenthal, André ^d   Schlegelberger, Brigitte ^k   Morris, Stephan W ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^c GENENTECH INC   (United States)

^d MetaGen Gesell Genomforschung mbH   (Germany)

^e UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^f UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^g HANUSCH HOSPITAL   (Austria)

^h GENERAL HOSPITAL LINZ   (Austria)

ⁱ Laboratoire d'Hématologie Ctr Hosp Lyon Sud Univ Claude B   (Germany)

^j CENTRE HOSPITALIER LYON SUD   (France)

^k UNIVERSITY OF KIEL   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE;

ARTICLE; CANCER GENETICS; CARBOXY TERMINAL SEQUENCE; CHROMOSOME TRANSLOCATION 1; CHROMOSOME TRANSLOCATION 14; GENE INACTIVATION; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

EID: 0032958801     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/8767     Document Type: Article

References (27)

1. Zucca, E., Roggero, E. & Pileri, S. B-cell lymphoma of MALT type: a review with special emphasis on diagnostic and management problems of low-grade gastric tumours. Br. J. Haematol. 100, 3-14 (1998).
2. Hofmann, K., Bucher, P. & Tschopp, J. The CARD domain: a new apoptotic signaling motif. Trends Biochem. Sci. 22, 155-156 (1997).
3. Wotherspoon, A.C., Pan, L., Diss, T.C. & Isaacson, P.G. Cytogenetic study of B-cell lymphoma of mucosa-associated lymphoid tissue. Cancer Genet. Cytogenet. 58, 35-38 (1992).
4. Offit, K., Jhanwar, S.C., Ladanyi, M., Filippa, D.A. & Chaganti, R.S. Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: correlations between recurrent aberrations, histology, and exposure to cytotoxic treatment. Genes Chromosomes Cancer 3, 189-201 (1991).
5. Tilly, H. et al. Prognostic value of chromosomal abnormalities in follicular lymphoma. Stood 84, 1043-1049 (1994).
6. Schlegelberger, B. et al. Cytogenetic findings and results of combined immunophenotyping and karyotyping in Hodgkin's disease. Leukemia 8, 72-80 (1994).
7. Telford, E.A.R., Watson, M.S., Aird, H.C., Perry, J. & Davison, A.J. The DNA sequence of equine herpesvirus 2. J. Mol. Biol. 249, 520-528 (1995).
8. Cesarman, E. & Knowles, D.M. Kaposi's sarcoma-associated herpesvirus: a lymphotropic human herpesvirus associated with Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. Semin. Diagn. Pathol. 14, 54-66 (1997).
9. Chou, J.J., Matsuo, H., Duan, H. & Wagner, G. Solution structure of the RAIDD CARD and model for CARD/CARD interaction in caspase-2 and caspase-9 recruitment. Cell 94, 171-180 (1998).
10. Yan, M., Lee, J., Schilbach, S., Goddard, A. & Dixi,. V. mE10, a novel CARD-containing proapoptotic molecule. J. biol. Chem. 274, 10287-10292 (1999).
11. Yin, C., Knudson, M., Korsmeyer, S.J. & Van Dyke, T. Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature 385, 637-640 (1997).
12. Storb, U. Progress in understanding the mechanism and consequences of somatic hypermutation. Immunol. Rev. 162, 5-11 (1998).
13. Shen, H.M., Peters, A., Baron, B., Zhu, X. & Storb, U. Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes. Science 280, 1750-1752 (1998).
14. Sonenshein, G.E. Rel/NF-κB transcription factors and the control of apoptosis. Semin. Cancer Biol. 8, 113-119 (1997).
15. Wang, C.Y., Mayo, M.W., Korneluk, R.G., Goeddel, D.V. & Baldwin, A.S. Jr NF-κB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and C-IAP2 to suppress caspase-8 activation. Science 281, 1630-1683 (1998).
16. Snow, E.C. The role of c-myc during normal B cell proliferation, and as B cells undergo malignant transformation. Curr. Top. Microbiol. Immunol. 224, 211-220 (1997).
17. Mayo, M.W. et al. Requirement of NF-κB activation to suppress p53-independent apoptosis induced by oncogenic Ras. Science 278, 1812-1815 (1997).
18. Besancon, F., Atfi, A., Gespach, C., Cayre, Y.E. & Bourgeade, M.F. Evidence for a role of NF-κB in the survival of hematopoietic cells mediated by interleukin 3 and the oncogenic TEL/platelet-derived growth factor receptor β fusion protein. Proc. Natl Acad. Sci. USA 95, 8081-8086 (1998).
19. Reuther, J.Y., Reuther, G.W., Cortez, D., Pendergast, A.M. & Baldwin, A.S. Jr A requirement for NF-κB activation in Bcr-Abl-mediated transformation. Genes Dev. 12, 968-981 (1998).
20. Lee, H. et al. Role of the Rel-family of transcription factors in the regulation of c-myc gene transcription and apoptosis of WEHI 231 murine B-cells. Curr. Top. Microbiol. Immunol. 194, 247-255 (1995).
21. Baeuerle, P.A. & Baltimore, D. NF-κB: ten years after. Cell 87, 13-20 (1996).
22. Gerondakis, S., Grumont, R., Rourke, I. & Grossmann, M. The regulation and roles of Rel/NF-κB transcription factors during lymphocyte activation. Curr. Opin. Immunol. 10, 353-359 (1998).
23. Luque, I. & Gelinas, C. Rel/NF-κB and IκB factors in oncogenesis. Semin. Cancer Biol. 8, 103-111 (1997).
24. Willis, T.G. et al. Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell 96, 35-45 (1999).
25. Willis, T.G. et al. Rapid molecular cloning of rearrangements of the IGHJ locus using long-distance inverse polymerase chain reaction. Blood 90, 2456-2464 (1997).
26. Siebert, R. et al. Application of interphase fluorescence in situ hybridization for the detection of the Burkitt translocation t(8;14)(q24;q32) in B-cell lymphomas. Blood 91, 984-990 (1998).
27. McCarthy, J.V., Ni, J. & Dixit, V.M. RIP2 is a novel NF-κB-activating and cell death-inducing kinase. J. Biol. Chem. 273, 16968-16975 (1998).